A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
11/2001
11/21/2001	EP1154796A1 Novel albumin-free factor viii formulations
11/21/2001	EP1154782A1 Taxane derivatives for targeted therapy of cancer
11/21/2001	EP1154778A2 Pharmaceutical preparation containing dithranol
11/21/2001	EP1154775A1 Therapeutic aqueous composition containing a hexahydro-5-pyrimidinamine compound and a polyalkoxylated fatty alcohol
11/21/2001	EP1154770A2 Premixed formulation of piperacillin sodium and tazobactam sodium injection
11/21/2001	EP1154767A1 Substituted stilbene compounds with vascular damaging activity
11/21/2001	EP1154765A1 Effervescent laxatives
11/21/2001	EP1154761A1 Solid oral dosage form containing an enhancer
11/21/2001	EP1154759A1 Dispersible concentrate for the delivery of cyclosporin
11/21/2001	EP1154757A1 Fast dispersing dosage forms free of gelatin
11/21/2001	EP1154756A2 Antibody fragment-targeted immunoliposomes for systemic gene delivery
11/21/2001	EP1154755A1 Liposome formulations
11/21/2001	EP1154734A1 Injectable collagen-based system for delivery of cells or therapeutic agents
11/21/2001	EP0895473B1 Polysaccharide microspheres for the pulmonary delivery of drugs
11/21/2001	EP0874643B1 Bioresponsive pharmacologically-active polymers and articles made therefrom
11/21/2001	EP0836645A4 Dry powder formulations of polynucleotide complexes
11/21/2001	EP0833667A4 Stabilization of polynucleotide complexes
11/21/2001	EP0706398B1 Pharmaceutical composition containing heparin, heparin fragments or their derivatives in combination with glycerol esters
11/21/2001	EP0643737B1 Conversion of powdered polymers
11/21/2001	CN1323348A Delivery system for porcine somatotropin
11/21/2001	CN1323345A A modified polypeptide with reduced immune response
11/21/2001	CN1323228A Methods instruments and materials for chondrocyte cell transplantation
11/21/2001	CN1323225A Polymer conjugates of interferon beta-1a and their uses
11/21/2001	CN1323221A Immunogenic beta-propionamido-linked polysaccharide protein conjugate useful as a vaccine produced using an N-acryloylated polysaccharide
11/21/2001	CN1323220A Insulin preparations for pulmonary delivery containing menthol
11/21/2001	CN1323219A Stable concentrated insulin preparations for pulmonary delivery
11/21/2001	CN1323213A Blood-brain barrier therapeutics
11/21/2001	CN1323202A Sertraline oral concentrate
11/21/2001	CN1323201A Extended release buccal bioadhesive tablet
11/21/2001	CN1323200A New oral formulation for 5-HT4 agonists or antagonists
11/21/2001	CN1323199A Liposome-entrapped topoisomerase inhibitors
11/21/2001	CN1323198A Method for preparing a solution for nasal spray containing sex hormones and a cyclodextrin
11/21/2001	CN1323194A UV protection compositions
11/21/2001	CN1323186A Two chamber cartridge for atomizers
11/21/2001	CN1323170A Nutritional and pharmaceutical compositions
11/21/2001	CN1322759A Composition for stimulating megacaryocyte growth and differentiation and process thereof
11/21/2001	CN1075078C Producing process of stem cell factor
11/21/2001	CN1075064C New benzoxazinedione derivatives, and producing process thereof and use
11/21/2001	CN1074932C Ophthalmic compositions
11/21/2001	CN1074927C Active medical component of 'Duanshepiju' its extraction process and medicine containing the same
11/21/2001	CN1074923C Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
11/21/2001	CN1074922C Oral liquid composition containing paroxetine resinate
11/21/2001	CN1074898C Ionene polymers, producing process, its intermediate and use
11/20/2001	US6320040 Preparing novel nucleoside oligomers bearing pendant conjugate groups for incorporation into nucleic acids
11/20/2001	US6320030 Mucin-biomolecules complex for transfection
11/20/2001	US6320029 Methods of production and use of liquid formulations of plasma proteins
11/20/2001	US6319984 Biodegradable and thermosensitive polyphosphazenes and their preparation method
11/20/2001	US6319952 Exposing the membrane to branched fatty acids or their salts, esters or amides which improve and enable the penetration and absorption of active ingredients through biomembranes
11/20/2001	US6319945 Applying ivermectin lotion or cream daily for 7 days and repeating such application one to four times per month for a period of several months.
11/20/2001	US6319943 Oral formulation for paclitaxel
11/20/2001	US6319914 Administering polycyclic phenolic formulation dose to population of cells to confer cytoprotection
11/20/2001	US6319913 Penetration enhancing and irritation reducing systems
11/20/2001	US6319896 Adding aqueous solution of charged polymer to solution of purified protein to reduce intermolecular or intramolecular interactions between the positively and negatively charged domains whereby solubility of protein is increased
11/20/2001	US6319891 Method of diagnosing and treating gliomas
11/20/2001	US6319702 Nucleotide sequencs coding an enzymatic polypeptide and cell targeting compound; for use in treatment of cancer
11/20/2001	US6319520 Copolymers of ammonium methacrylate that consist of fully polymerized copolymers of acrylic acid and methacrylic acid ester having quaternary ammonium groups
11/20/2001	US6319518 Colon selective drug delivery composition
11/20/2001	US6319517 Pharmaceutical preparation comprising lyophilized liposomes encapsulating an active principle which is highly insoluble in water, and the process for preparing the said preparation
11/20/2001	US6319516 Lipophilic group, linker bond, spacer arm and a cationic amino group; stability;
11/20/2001	US6319513 Oral liquid mucoadhesive compounds
11/20/2001	US6319512 Implants for controlled release of pharmaceutically active principles and method for making same
11/20/2001	US6319510 Pad to be installed on gum comprising nonporous layer, adjacent layer retaining medication capable of being liquefied by saliva, semipermeable layer covering second layer and sealed to first layer to form pocket enclosing second layer
11/20/2001	US6319509 Pharmaceutical composition
11/20/2001	US6319500 Detection and treatment of infections with immunoconjugates
11/20/2001	US6319490 Liquid oral compositions comprising a calcium compound and an acidulant
11/20/2001	US6319464 Added to borate containing compound; antimicrobial activity enhancement
11/20/2001	CA2090404C Nonaqueous fluorinated drug delivery vehicle suspensions
11/20/2001	CA2086121C Ophthalmic suspensions
11/20/2001	CA2077691C Oxidation resistant thrombomodulin analogs
11/20/2001	CA2017851C Micronised biodegradable particles, process for preparing them and the use thereof
11/18/2001	CA2345482A1 Use of paclitaxel stabilized with albumin for preparing a drug for the treatment of solid tumors and the drug obtained thereby
11/15/2001	WO2001085960A1 Bacterial carboxypeptidase cpg2 variants and their use in gene directed enzyme prodrug therapy
11/15/2001	WO2001085845A1 Wound gels
11/15/2001	WO2001085800A2 Esterified polysaccharide products and η-lactone ring opened ketene dimer products containing the compositions, and process of making the same
11/15/2001	WO2001085798A2 Human monoclonal antibodies to dendritic cells
11/15/2001	WO2001085790A2 Mammalian cytokine receptor subunit proteins, related reagents and methods
11/15/2001	WO2001085777A2 Therapeutic pore-forming peptides
11/15/2001	WO2001085699A2 Prodrugs of hiv replication inhibiting pyrimidines
11/15/2001	WO2001085681A2 3-methoxybenzyl thiourea derivatives and improved lipid compositions containing same
11/15/2001	WO2001085345A1 Media milling
11/15/2001	WO2001085257A2 Opioid antagonist compositions and dosage forms
11/15/2001	WO2001085219A2 Identification, diagnosis, and treatment of breast cancer
11/15/2001	WO2001085218A2 Acylated cyclodextrin guest inclusion complexes
11/15/2001	WO2001085217A1 Gel-like pharmaceutical composition for subcutaneous administration comprising bisphosphonic acids or their salts
11/15/2001	WO2001085216A1 Method for the preparation of polymeric micelle via phase separation of block copolymer
11/15/2001	WO2001085200A2 Recombinant human cln2 protein and methods of its production and use
11/15/2001	WO2001085184A2 Nontoxic vernix compositions and method of producing
11/15/2001	WO2001085181A1 Therapeutical composition comprising iodine tincture, alcohol and castor oil for treatment of psoriasis
11/15/2001	WO2001085180A1 Biocompatible macromers
11/15/2001	WO2001085174A1 Formulations containing a glucocorticoid drug for the treatment of bronchopulmonary diseases
11/15/2001	WO2001085156A1 Dermal compositions containing coenzyme q as the active ingredient
11/15/2001	WO2001085148A2 Packaging regimen of pseudoephedrine hydrochloride and fexofenadine hydrocloride
11/15/2001	WO2001085147A2 STABILIZED FORMULATIONS OF 6-HYDROXY-3-(4-[2-(PIPERIDIN-1-YL) ETHOXY]PHENOXY)-2-(4-METHOXYPHENYL) BENZO[b]THIOPHENE AND SALTS THEREOF
11/15/2001	WO2001085143A2 Pharmaceutical compositions for transdermal administration of anti-inflammatory agents
11/15/2001	WO2001085142A1 Compositions and methods for protecting cells during cancer chemotherapy and radiotherapy
11/15/2001	WO2001085141A1 β-GLUCANS ENCAPSULATED IN LIPOSOMES
11/15/2001	WO2001085139A2 Semi-solid delivery vehicle and pharmaceutical compositions
11/15/2001	WO2001085137A2 Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
11/15/2001	WO2001085136A2 Phospholipid-based powders for drug delivery
11/15/2001	WO2001085128A2 Skin protectant spray compositions

1 ... 1283 1284 1285 1286 1287 1288 1289 1290 1291 1292 1293 1294 1295 1296 1297 1298 1299 1300 1301 1302 1303 ... 1712